The influence of cognitive ability in Chinese reading comprehension: can working memory updating change Chinese primary school students’ reading comprehension performance?

With the development of educational cognitive neuroscience, language instruction is no longer perceived as mechanical teaching and learning. Individual cognitive proficiency has been found to play a crucial role in language acquisition, particularly in the realm of reading comprehension. The primary objective of this study was to investigate two key aspects: firstly, to assess the predictive effects of the central executive (CE) on the Chinese reading comprehension scores of Chinese primary school students, and secondly, to explore the influence of CE training on the Chinese reading comprehension performance of Chinese primary school students. Chinese primary school students were recruited as participants. Experiment 1 used a Chinese N-back task, a Chinese Stroop task, and a number-pinyin conversion task to investigate the predictive effect of the CE components on Chinese reading comprehension. Experiment 2, based on the results of Experiment 1, used the Chinese character N-back training to explore the influence of updating training on Chinese reading comprehension. The findings from Experiment 1 underscored that CE had a predictive effect on Chinese reading comprehension scores. And updating had a prominent role in it. Experiment 2 revealed that the experimental group exhibited an enhancement in their updating performance following N-back training. Although the reading comprehension performance of the two groups after training did not produce significant differences in total scores, the experimental group showed maintained and higher microscopic reading comprehension scores than the control group in the more difficult post-test. In summary, this study yields two primary conclusions: (1) CE was able to predict Chinese reading comprehension scores. Updating has an important role in prediction. (2) Updating training enhances students’ updating performance and positively influences students’ Chinese microscopic reading comprehension performance

Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline

Background: The gut microbiome and fecal metabolites have been found to influence sarcopenia, but whether there are potential bacteria that can alleviate sarcopenia has been under-investigated, and the molecular mechanism remains unclear.Methods: To investigate the relationships between the gut microbiome, fecal metabolites and sarcopenia, subjects were selected from observational multi-ethnic study conducted in Western China. Sarcopenia was diagnosed according to the criteria of the Asian Working Group for Sarcopenia 2014. The gut microbiome was profiled by shotgun metagenomic sequencing. Untargeted metabolomic analysis was performed to analyse the differences in fecal metabolites. We investigated bacterium with the greatest relative abundance difference between healthy individuals and sarcopenia patients, and the differences in metabolites associated with the bacteria, to verify its effects on muscle mass and function in a mouse model.Results: The study included 283 participants (68.90% females, mean age: 66.66 years old) with and without sarcopenia (141 and 142 participants, respectively) and from the Han (98 participants), Zang (88 participants) and Qiang (97 participants) ethnic groups. This showed an overall reduction (15.03% vs. 20.77%, P = 0.01) of Prevotella copri between the sarcopenia and non-sarcopenia subjects across the three ethnic groups. Functional characterization of the differential bacteria showed enrichment (odds ratio = 15.97, P = 0.0068) in branched chain amino acid (BCAA) metabolism in non-sarcopenia group. A total of 13 BCAA and their derivatives have relatively low levels in sarcopenia. In the in vivo experiment, we found that the blood BCAA level was higher in the mice gavaged with live P. copri (LPC) (P &lt; 0.001). The LPC mice had significantly longer wire and grid hanging time (P &lt; 0.02), longer time on rotor (P = 0.0001) and larger grip strength (P &lt; 0.0001), indicating better muscle function. The weight of gastrocnemius mass and rectus femoris mass (P &lt; 0.05) was higher in LPC mice. The micro-computed tomography showed a larger leg area (P = 0.0031), and a small animal analyser showed a higher lean mass ratio in LPC mice (P = 0.0157), indicating higher muscle mass.Conclusions: The results indicated that there were lower levels of both P. copri and BCAA in sarcopenia individuals. In vivo experiments, gavage with LPC could attenuate muscle mass and function decline, indicating alleviating sarcopenia. This suggested that P. copri may play a therapeutic potential role in the management of sarcopenia.</p

Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline

Background: The gut microbiome and fecal metabolites have been found to influence sarcopenia, but whether there are potential bacteria that can alleviate sarcopenia has been under-investigated, and the molecular mechanism remains unclear.Methods: To investigate the relationships between the gut microbiome, fecal metabolites and sarcopenia, subjects were selected from observational multi-ethnic study conducted in Western China. Sarcopenia was diagnosed according to the criteria of the Asian Working Group for Sarcopenia 2014. The gut microbiome was profiled by shotgun metagenomic sequencing. Untargeted metabolomic analysis was performed to analyse the differences in fecal metabolites. We investigated bacterium with the greatest relative abundance difference between healthy individuals and sarcopenia patients, and the differences in metabolites associated with the bacteria, to verify its effects on muscle mass and function in a mouse model.Results: The study included 283 participants (68.90% females, mean age: 66.66 years old) with and without sarcopenia (141 and 142 participants, respectively) and from the Han (98 participants), Zang (88 participants) and Qiang (97 participants) ethnic groups. This showed an overall reduction (15.03% vs. 20.77%, P = 0.01) of Prevotella copri between the sarcopenia and non-sarcopenia subjects across the three ethnic groups. Functional characterization of the differential bacteria showed enrichment (odds ratio = 15.97, P = 0.0068) in branched chain amino acid (BCAA) metabolism in non-sarcopenia group. A total of 13 BCAA and their derivatives have relatively low levels in sarcopenia. In the in vivo experiment, we found that the blood BCAA level was higher in the mice gavaged with live P. copri (LPC) (P &lt; 0.001). The LPC mice had significantly longer wire and grid hanging time (P &lt; 0.02), longer time on rotor (P = 0.0001) and larger grip strength (P &lt; 0.0001), indicating better muscle function. The weight of gastrocnemius mass and rectus femoris mass (P &lt; 0.05) was higher in LPC mice. The micro-computed tomography showed a larger leg area (P = 0.0031), and a small animal analyser showed a higher lean mass ratio in LPC mice (P = 0.0157), indicating higher muscle mass.Conclusions: The results indicated that there were lower levels of both P. copri and BCAA in sarcopenia individuals. In vivo experiments, gavage with LPC could attenuate muscle mass and function decline, indicating alleviating sarcopenia. This suggested that P. copri may play a therapeutic potential role in the management of sarcopenia.</p

Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline

Background: The gut microbiome and fecal metabolites have been found to influence sarcopenia, but whether there are potential bacteria that can alleviate sarcopenia has been under-investigated, and the molecular mechanism remains unclear.Methods: To investigate the relationships between the gut microbiome, fecal metabolites and sarcopenia, subjects were selected from observational multi-ethnic study conducted in Western China. Sarcopenia was diagnosed according to the criteria of the Asian Working Group for Sarcopenia 2014. The gut microbiome was profiled by shotgun metagenomic sequencing. Untargeted metabolomic analysis was performed to analyse the differences in fecal metabolites. We investigated bacterium with the greatest relative abundance difference between healthy individuals and sarcopenia patients, and the differences in metabolites associated with the bacteria, to verify its effects on muscle mass and function in a mouse model.Results: The study included 283 participants (68.90% females, mean age: 66.66 years old) with and without sarcopenia (141 and 142 participants, respectively) and from the Han (98 participants), Zang (88 participants) and Qiang (97 participants) ethnic groups. This showed an overall reduction (15.03% vs. 20.77%, P = 0.01) of Prevotella copri between the sarcopenia and non-sarcopenia subjects across the three ethnic groups. Functional characterization of the differential bacteria showed enrichment (odds ratio = 15.97, P = 0.0068) in branched chain amino acid (BCAA) metabolism in non-sarcopenia group. A total of 13 BCAA and their derivatives have relatively low levels in sarcopenia. In the in vivo experiment, we found that the blood BCAA level was higher in the mice gavaged with live P. copri (LPC) (P &lt; 0.001). The LPC mice had significantly longer wire and grid hanging time (P &lt; 0.02), longer time on rotor (P = 0.0001) and larger grip strength (P &lt; 0.0001), indicating better muscle function. The weight of gastrocnemius mass and rectus femoris mass (P &lt; 0.05) was higher in LPC mice. The micro-computed tomography showed a larger leg area (P = 0.0031), and a small animal analyser showed a higher lean mass ratio in LPC mice (P = 0.0157), indicating higher muscle mass.Conclusions: The results indicated that there were lower levels of both P. copri and BCAA in sarcopenia individuals. In vivo experiments, gavage with LPC could attenuate muscle mass and function decline, indicating alleviating sarcopenia. This suggested that P. copri may play a therapeutic potential role in the management of sarcopenia.</p

Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline

Background: The gut microbiome and fecal metabolites have been found to influence sarcopenia, but whether there are potential bacteria that can alleviate sarcopenia has been under-investigated, and the molecular mechanism remains unclear.Methods: To investigate the relationships between the gut microbiome, fecal metabolites and sarcopenia, subjects were selected from observational multi-ethnic study conducted in Western China. Sarcopenia was diagnosed according to the criteria of the Asian Working Group for Sarcopenia 2014. The gut microbiome was profiled by shotgun metagenomic sequencing. Untargeted metabolomic analysis was performed to analyse the differences in fecal metabolites. We investigated bacterium with the greatest relative abundance difference between healthy individuals and sarcopenia patients, and the differences in metabolites associated with the bacteria, to verify its effects on muscle mass and function in a mouse model.Results: The study included 283 participants (68.90% females, mean age: 66.66 years old) with and without sarcopenia (141 and 142 participants, respectively) and from the Han (98 participants), Zang (88 participants) and Qiang (97 participants) ethnic groups. This showed an overall reduction (15.03% vs. 20.77%, P = 0.01) of Prevotella copri between the sarcopenia and non-sarcopenia subjects across the three ethnic groups. Functional characterization of the differential bacteria showed enrichment (odds ratio = 15.97, P = 0.0068) in branched chain amino acid (BCAA) metabolism in non-sarcopenia group. A total of 13 BCAA and their derivatives have relatively low levels in sarcopenia. In the in vivo experiment, we found that the blood BCAA level was higher in the mice gavaged with live P. copri (LPC) (P &lt; 0.001). The LPC mice had significantly longer wire and grid hanging time (P &lt; 0.02), longer time on rotor (P = 0.0001) and larger grip strength (P &lt; 0.0001), indicating better muscle function. The weight of gastrocnemius mass and rectus femoris mass (P &lt; 0.05) was higher in LPC mice. The micro-computed tomography showed a larger leg area (P = 0.0031), and a small animal analyser showed a higher lean mass ratio in LPC mice (P = 0.0157), indicating higher muscle mass.Conclusions: The results indicated that there were lower levels of both P. copri and BCAA in sarcopenia individuals. In vivo experiments, gavage with LPC could attenuate muscle mass and function decline, indicating alleviating sarcopenia. This suggested that P. copri may play a therapeutic potential role in the management of sarcopenia.</p

Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline

Background: The gut microbiome and fecal metabolites have been found to influence sarcopenia, but whether there are potential bacteria that can alleviate sarcopenia has been under-investigated, and the molecular mechanism remains unclear.Methods: To investigate the relationships between the gut microbiome, fecal metabolites and sarcopenia, subjects were selected from observational multi-ethnic study conducted in Western China. Sarcopenia was diagnosed according to the criteria of the Asian Working Group for Sarcopenia 2014. The gut microbiome was profiled by shotgun metagenomic sequencing. Untargeted metabolomic analysis was performed to analyse the differences in fecal metabolites. We investigated bacterium with the greatest relative abundance difference between healthy individuals and sarcopenia patients, and the differences in metabolites associated with the bacteria, to verify its effects on muscle mass and function in a mouse model.Results: The study included 283 participants (68.90% females, mean age: 66.66 years old) with and without sarcopenia (141 and 142 participants, respectively) and from the Han (98 participants), Zang (88 participants) and Qiang (97 participants) ethnic groups. This showed an overall reduction (15.03% vs. 20.77%, P = 0.01) of Prevotella copri between the sarcopenia and non-sarcopenia subjects across the three ethnic groups. Functional characterization of the differential bacteria showed enrichment (odds ratio = 15.97, P = 0.0068) in branched chain amino acid (BCAA) metabolism in non-sarcopenia group. A total of 13 BCAA and their derivatives have relatively low levels in sarcopenia. In the in vivo experiment, we found that the blood BCAA level was higher in the mice gavaged with live P. copri (LPC) (P &lt; 0.001). The LPC mice had significantly longer wire and grid hanging time (P &lt; 0.02), longer time on rotor (P = 0.0001) and larger grip strength (P &lt; 0.0001), indicating better muscle function. The weight of gastrocnemius mass and rectus femoris mass (P &lt; 0.05) was higher in LPC mice. The micro-computed tomography showed a larger leg area (P = 0.0031), and a small animal analyser showed a higher lean mass ratio in LPC mice (P = 0.0157), indicating higher muscle mass.Conclusions: The results indicated that there were lower levels of both P. copri and BCAA in sarcopenia individuals. In vivo experiments, gavage with LPC could attenuate muscle mass and function decline, indicating alleviating sarcopenia. This suggested that P. copri may play a therapeutic potential role in the management of sarcopenia.</p

Controlling of structural ordering and rigidity of β-SiAlON:Eu through chemical cosubstitution to approach narrow-band-emission for light-emitting diodes application

The authors are grateful for the financial support of the Ministry of Science and Technology of Taiwan (Contract Nos. MOST 104- 2113-M-002-012-MY3, MOST 104-2119-M-002-027-MY3 and 104-2923-M-002-007-MY3) and Australia Research Council (ARC, FT160100251). The contribution of A. L. was supported by the grant “Preludium” UMO-2014/13/N/ST3/03781 from the National Science Center. The contribution of S. M. was supported by the grant “Iuventus Plus” 0271/IP3/2015/73 from the Ministry of Science and Higher Education. M. G. was supported by Polish National Center for Research and Development with grants no PBS3/A5/48/2015 and PL-TWII/8/2015.Narrow-band green-emitting phosphor β-SiAlON:Eu has been widely used in advanced wide-gamut backlighting de- vices. However, the origins for unusual sharp lines in photoluminescence emission at room temperature and tunable narrow-band- emission tailored by reducing Al-O in β-SiAlON:Eu are still unclear. Here, the presence of sharp-line fine structure in the emission spectra of β-SiAlON:Eu is mainly due to purely electronic transitions (zero phonon lines) and their vibronic repetitions resulted from the multi-microenvironment around Eu2+ ions that has been revealed by relative emission intensity of sharp line depends on excitation wavelength and monotonously increasing decay time. The specific features of the Eu2+ occupying interstitial sites indicate that the effect of crystal field strength can be neglected. Therefore the enhanced rigidity and higher ordering structure of β-SiAlON:Eu with decreasing the substitution of Si–N by Al–O become the main factors in decreasing electron–lattice coupling and reducing inhomo- geneous broadening, favouring the blue-shift and narrow of the emission band, the enhanced thermal stability, as well as the charge state of Eu2+. Our results provide new insights for explaining the reason for narrow-band-emission in β-SiAlON:Eu, which will deliver an impetus for the exploration of phosphors with narrow band and ordering structure.PostprintPeer reviewe

Vaccination mediates protection against Penicillium marneffei in BALB/c mice

P. marneffei is the unique thermal dimorphic fungus among Penicillium spp. which grows as mycelium at 25 ºC and as yeast at 37 ºC. Intravascular injection of lethal dose of P. marneffei spores might lead to systemic infections in BALB/c mice, and the hepatic tissue seemed to suffer from the most severe infection with significant high CFU value than other organs. In this study, we aimed at generating a candidate vaccine for P. marneffei using two independent approaches, recombinant Mp1p protein and live-attenuated strain vaccination. Antigenic mannoprotein Mp1p of P. marneffei strain PM1 was cloned and expressed in E. coli and Pichia pastoris, and these two types of recombinant Mp1p was used to perform vaccination study. Both subcutaneous administration of recombinant Mp1p with Freund’s Adjuvant and intraperitoneal injection of Mp1p with Sigma Adjuvant System elicited efficacious resistance against lethal dose challenge of PM1 in BALB/c mice. Four different strains PM1, PM18, PM25 and PM36 were chosen to detect the protective breadth of strain coverage of recombinant Mp1p and results showed that recombinant Mp1p only generated protection against strain PM1 but failed to resist against the infections of other P. marneffei isolates. Fungal burden and histopathological examination elucidated that recombinant Mp1p with SAS had efficacy in suppression and clearance of hepatic and splenic PM1 yeast cells, but failed to control the dissemination of PM25 which caused invasive hepatic and splenic infection and malignant inflammatory response. Thus, we hypothesized that recombinant Mp1p elicited a narrow breadth of strain coverage due to the high degree of polymorphism of MP1 and its homologues. Depletion of virulence gene MP1 from strain PM1 yielded one live-attenuated P. marneffei strain BC122. BC122 vaccinated mice were able to resist infections due to different P. marneffei isolates, including strain PM1, PM18, PM25 and PM36. Thus, it displayed wide strain coverage. Fungal burden analysis elucidated that both PM1 and PM25 yeast cells in mice spleens and livers presented a trend of clearance. H&E and GMS staining of vaccinated mice hepatic tissues founded that both PM1 and PM25 yeast cells were fast sequestered in granulomas and killed progressively, and many empty granulomas were seen since days 6 post-infection. Intracellular staining showed that the frequency of IFN-γ producing CD4+ T cells in hepatic tissue was significant higher than the peripheral blood, which might elucidate the influx of functional hepatic Th1 cells. The absolute number of hepatic Th1 cells in immunized mice were also significant greater than that of PBS control group. In addition, CD4 deficient mice seemed to be vulnerable even to the virulence attenuated strain BC122. Furthermore, the percentage of hepatic Th17 cells rocketed at days 2 post-infection then fast decreased to bottom out which was not consistent with the tendency of fungal clearance. Thus, we concluded that vaccine BC122 had elicited efficacious protection through hepatic Th1 cell immunity in BALB/c mice model. This preliminary study will help us to characterize the mechanisms of exclusive immune response against P. marneffei and provide informative reference for preventive or therapeutic strategies against penicilliosis.published_or_final_versionMicrobiologyDoctoralDoctor of Philosoph

Research on Impact Factors of Smart Elderly Care Mode and the Corresponding Industry: ──Taking Questionnaire Data of Some Cities in Jiangsu Province as An Example

With the development of Internet of things technology, the smart elderly care mode is attracting more and more attention. Based on the questionnaire data of adult residents in some cities of Jiangsu Province, this paper analyzes the multiple linear regression model between the intelligent elderly care mode and its possible influencing factors. And it can be found that for participants aged 59 and under, their educational level, blood type, professional identity and age have a significant impact on intelligent old-age care mode. For participants aged 60 and over, only their educational level and age have a significant impact on the smart old-age care approach. Finally, this paper puts forward some suggestions about the development of industries related to intelligent elderly care to build an integrated intelligent community old-age care pattern, integrated pattern of intelligent home-based care or integrated smart home-based care service center, adjust and perfect the existing elderly care institutions, and improve intelligence old-age care institutions pattern to promote the development of intelligent industry related to smart elderly care